5 research outputs found
Anatomical and histological study of kidney in Barbus grypus
At this study, kidneys of 10 normal fishes have been studied macroscopic and microscopically. The kidneys were collected by autopsy and tissue samples were sectioned by routine paraffin embedding and stained by H&E and PAS. Macroscopic observation showed that the kidney in Barbus grypus situated in the ventral region of vertebral column. The kidney could be divided into; head, body and tail portions according to their relative position. Microscopic studies showed that the kidneys consisted of excretory portion and hematopoietic-lymphoid tissues. Anterior portion of kidney (head) had more Hematopoietic lymphoid tissues than the posterior portion (body and tail). Hematopoietic-lymphoid tissue consisted of cells which were found in different stages of development to blood cells. Excretory portion of kidney parenchyma consisted of renal corpuscle and urinary tubules. In microscopic section of glomerulus, endothelial and mesangial cells and nucleated red blood cells were seen. The number of renal corpuscles in the posterior portion of kidney was more than the anterior portion significantly, while there was no significant difference between the average diameter of renal corpuscles in the head, body and tail portions of kidney. Urinary tubules consisted of neck segment, proximal tubule (first and second portion), intermediate segment and distal segment. The collecting ducts were situated after the distal segments. No significant difference was observed in the measured parameters between the males and females fishes in this study. Based on the results of this study, the kidney of Barbus grypus is very similar to other species of the family Cyprinidae, histologically and anatomically
Histological and histomorphometrical study of intestinal bulb in shirbot, Barbus grypus
Barbus grypus is native fishes in Khuzestan province which its species with a wide distribution in the rivers that considered fisheries research in province. The fish have no stomach, space of intestine is narrow to store of food, for this reason anterior intestine dilated bowel and called intestinal bulb. Study of histological structure of intestinal bulb in fishes can help to nutrition and food needs so that we can extend of this species. In this study, 10 adults Barbus grypus of both sexes with average weigh 354.25 ± 60.52 g and average length 36.25 ±4.16 cm was chosen, and after easy drawing, samples were removed from intestinal bulb. The 0.5cm were fixed by Bouin´s fixative soluble and 5-6µ thickness sections were made by paraffin embedding method and were stained by H&E and PAS. The histomorphometrical studies were done using digital Dino-Lite lens and Dino-capture1 software. The results showed that the number of goblet cells in the intestine increased toward the end of the intestinal bulb. The intestinal epithelium height in the anterior part of the intestinal bulb was higher than other parts. Muscular thickness was different in different parts of the intestinal bulb; the middle part of intestinal bulb has thickest muscle between other parts of intestinal bulb. The results of this research indicate that there is some analog histological structure of the intestinal bulb in Barbus grypus to compare of other same family: from wall diameter and intestinal epithelium height and diameter of mucosa
Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials
Inflammatory bowel diseases (IBDs) may result from mutations in genes encoding for innate immunity, which can lead to exacerbated inflammatory response. Although some mono-targeted treatments have developed in recent years, IBDs are caused through several pathway perturbations. Therefore, targeting all these pathways is difficult to be achieved by a single agent. Moreover, those mono-targeted therapies are usually expensive and may cause side-effects. These limitations highlight the significance of an available, inexpensive and multi-targeted dietary agents or natural compounds for the treatment and prevention of IBDs. Curcumin is a multifunctional phenolic compound that is known for its anti-inflammatory and immunomodulatory properties. Over the past decades, mounting experimental investigations have revealed the therapeutic potential of curcumin against a broad spectrum of inflammatory diseases including IBDs. Furthermore, it has been reported that curcumin directly interacts with many signaling mediators implicated in the pathogenesis of IBDs. These preclinical findings have created a solid basis for the assessment of the efficacy of curcumin in clinical practice. In clinical trials, different dosages e.g., 550 mg /three times daily-1month, and 1 g /twice times daily-6month of curcumin were used for patients with IBDs. Taken together, these findings indicated that curcumin could be employed as a therapeutic candidate in the treatment of IBDs. Moreover, it seems that overcome to current limitations of curcumin i.e., poor oral bioavailability, and poor oral absorption with using nanotechnology and others, could improve the efficacy of curcumin both in pre-clinical and clinical studies. © 2020 Elsevier Lt